Infiltrating Bladder Urothelial Carcinoma
| Drug | Drug Name | Drug Description |
|---|
| Drug | Drug Name | Target | Type |
|---|
| Drug | Drug Name | Phase | Status | Count |
|---|---|---|---|---|
| DB14797 | SEphB4-HSA | 1 | Terminated | 1 |
| DB11714 | Durvalumab | 1 / 2 | Active Not Recruiting | 1 |
| DB11771 | Tremelimumab | 1 / 2 | Active Not Recruiting | 1 |
| DB06772 | Cabazitaxel | 2 | Active Not Recruiting | 1 |
| DB00515 | Cisplatin | 2 | Active Not Recruiting | 1 |
| DB00515 | Cisplatin | 2 | Recruiting | 1 |
| DB00441 | Gemcitabine | 2 | Recruiting | 1 |
| DB00019 | Pegfilgrastim | 2 | Recruiting | 1 |
| DB09037 | Pembrolizumab | 2 | Withdrawn | 1 |
| DB14547 | Chloride ion | Not Available | Withdrawn | 1 |
| DB00515 | Cisplatin | Not Available | Withdrawn | 1 |
| DB00441 | Gemcitabine | Not Available | Withdrawn | 1 |
| DB12257 | Platinum | Not Available | Withdrawn | 1 |